Skip to content
Ejaculation.org

Case series · 2011

Hyposensitization therapy with autologous semen in two Dutch caucasian males: beneficial effects in Postorgasmic Illness Syndrome (POIS; Part 2)

Waldinger MD, Meinardi MM, Schweitzer DH (2011). Hyposensitization therapy with autologous semen in two Dutch caucasian males: beneficial effects in Postorgasmic Illness Syndrome (POIS; Part 2). The Journal of Sexual Medicine. doi:10.1111/j.1743-6109.2010.02167.x

Key finding
Two men with POIS and a positive skin test to their own semen received years of injections of their diluted semen; their symptoms improved by 60% at 31 months and 90% at 15 months.

Summary

Based on an allergic hypothesis for postorgasmic illness syndrome (POIS), the authors treated two men with hyposensitization: repeated injections under the skin of their own (autologous) semen, starting very diluted and slowly increasing in strength. Injections were given every two weeks in the first year and gradually every four weeks in the second and third years.

Both men had confirmed POIS and positive skin-prick tests to their own semen. Complaints improved by 60% and 90% at 31 and 15 months respectively. In the man who also had lifelong premature ejaculation, latency increased from 20 seconds to 10 minutes after three years, for reasons the authors could not explain.

Limitations

This is a report of two men, without a control group or blinding. Treatment took years and was given in a specialist setting. A 2025 systematic review found the evidence on all POIS treatments limited mostly to case reports.

What it means for you

Hyposensitization is the treatment most closely linked to the allergy theory of POIS, but the evidence comes from a handful of patients. It is a specialist treatment to discuss with a urologist or allergist, not something to try yourself.